810 related articles for article (PubMed ID: 34033488)
1. Early Breast Cancer Detection Using Untargeted and Targeted Metabolomics.
Wei Y; Jasbi P; Shi X; Turner C; Hrovat J; Liu L; Rabena Y; Porter P; Gu H
J Proteome Res; 2021 Jun; 20(6):3124-3133. PubMed ID: 34033488
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer detection using targeted plasma metabolomics.
Jasbi P; Wang D; Cheng SL; Fei Q; Cui JY; Liu L; Wei Y; Raftery D; Gu H
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jan; 1105():26-37. PubMed ID: 30562627
[TBL] [Abstract][Full Text] [Related]
3. Metabolomics of papillary thyroid carcinoma tissues: potential biomarkers for diagnosis and promising targets for therapy.
Shang X; Zhong X; Tian X
Tumour Biol; 2016 Aug; 37(8):11163-75. PubMed ID: 26935059
[TBL] [Abstract][Full Text] [Related]
4. Coccidioidomycosis Detection Using Targeted Plasma and Urine Metabolic Profiling.
Jasbi P; Mitchell NM; Shi X; Grys TE; Wei Y; Liu L; Lake DF; Gu H
J Proteome Res; 2019 Jul; 18(7):2791-2802. PubMed ID: 31244214
[TBL] [Abstract][Full Text] [Related]
5. LC-MS/MS platform-based serum untargeted screening reveals the diagnostic biomarker panel and molecular mechanism of breast cancer.
Gong S; Wang Q; Huang J; Huang R; Chen S; Cheng X; Liu L; Dai X; Zhong Y; Fan C; Liao Z
Methods; 2024 Feb; 222():100-111. PubMed ID: 38228196
[TBL] [Abstract][Full Text] [Related]
6. Triple Negative Breast Cancer Detection Using LC-MS/MS Lipidomic Profiling.
Eghlimi R; Shi X; Hrovat J; Xi B; Gu H
J Proteome Res; 2020 Jun; 19(6):2367-2378. PubMed ID: 32397718
[TBL] [Abstract][Full Text] [Related]
7. Next-generation metabolic screening: targeted and untargeted metabolomics for the diagnosis of inborn errors of metabolism in individual patients.
Coene KLM; Kluijtmans LAJ; van der Heeft E; Engelke UFH; de Boer S; Hoegen B; Kwast HJT; van de Vorst M; Huigen MCDG; Keularts IMLW; Schreuder MF; van Karnebeek CDM; Wortmann SB; de Vries MC; Janssen MCH; Gilissen C; Engel J; Wevers RA
J Inherit Metab Dis; 2018 May; 41(3):337-353. PubMed ID: 29453510
[TBL] [Abstract][Full Text] [Related]
8. Untargeted detection of the carbonyl metabolome by chemical derivatization and liquid chromatography-tandem mass spectrometry in precursor ion scan mode: Elucidation of COVID-19 severity biomarkers.
Gomez-Gomez A; Rodríguez-Morató J; Haro N; Marín-Corral J; Masclans JR; Pozo OJ
Anal Chim Acta; 2022 Mar; 1196():339405. PubMed ID: 35151400
[TBL] [Abstract][Full Text] [Related]
9. Screening by Q Exactive liquid chromatography/tandem mass spectrometry identified Choline, 25-hydroxyvitamin D2, and SM(d18:0/16:1(9Z) (OH)) as biomarkers for high-grade serous ovarian cancer.
Li J; Liu D; Cui M; Wei Z
J Proteomics; 2024 May; 299():105154. PubMed ID: 38471622
[TBL] [Abstract][Full Text] [Related]
10. Using post-column infused internal standard assisted quantitative metabolomics for establishing prediction models for breast cancer detection.
Huang M; Li HY; Liao HW; Lin CH; Wang CY; Kuo WH; Kuo CH
Rapid Commun Mass Spectrom; 2020 Apr; 34 Suppl 1():e8581. PubMed ID: 31693758
[TBL] [Abstract][Full Text] [Related]
11. Investigation of altered urinary metabolomic profiles of invasive ductal carcinoma of breast using targeted and untargeted approaches.
More TH; Taware R; Taunk K; Chanukuppa V; Naik V; Mane A; Rapole S
Metabolomics; 2018 Aug; 14(8):107. PubMed ID: 30830381
[TBL] [Abstract][Full Text] [Related]
12. An untargeted metabolomics-driven approach based on LC-TOF/MS and LC-MS/MS for the screening of xenobiotics and metabolites of Zhi-Zi-Da-Huang decoction in rat plasma.
Wu H; Li X; Yan X; An L; Luo K; Shao M; Jiang Y; Xie R; Feng F
J Pharm Biomed Anal; 2015 Nov; 115():315-22. PubMed ID: 26275719
[TBL] [Abstract][Full Text] [Related]
13. Metabolic profiling of potential lung cancer biomarkers using bronchoalveolar lavage fluid and the integrated direct infusion/ gas chromatography mass spectrometry platform.
Callejón-Leblic B; García-Barrera T; Grávalos-Guzmán J; Pereira-Vega A; Gómez-Ariza JL
J Proteomics; 2016 Aug; 145():197-206. PubMed ID: 27255828
[TBL] [Abstract][Full Text] [Related]
14. LC-MS untargeted metabolomics assesses the delayed response of glufosinate treatment of transgenic glufosinate resistant (GR) buffalo grasses (Stenotaphrum secundatum L.).
Boonchaisri S; Rochfort S; Stevenson T; Dias DA
Metabolomics; 2021 Feb; 17(3):28. PubMed ID: 33609206
[TBL] [Abstract][Full Text] [Related]
15. Untargeted saliva metabonomics study of breast cancer based on ultra performance liquid chromatography coupled to mass spectrometry with HILIC and RPLC separations.
Zhong L; Cheng F; Lu X; Duan Y; Wang X
Talanta; 2016 Sep; 158():351-360. PubMed ID: 27343615
[TBL] [Abstract][Full Text] [Related]
16. Development of simultaneous targeted metabolite quantification and untargeted metabolomics strategy using dual-column liquid chromatography coupled with tandem mass spectrometry.
Gao Y; Chen Y; Yue X; He J; Zhang R; Xu J; Zhou Z; Wang Z; Zhang R; Abliz Z
Anal Chim Acta; 2018 Dec; 1037():369-379. PubMed ID: 30292313
[TBL] [Abstract][Full Text] [Related]
17. Determining the presence of asthma-related molecules and salivary contamination in exhaled breath condensate.
Cruickshank-Quinn C; Armstrong M; Powell R; Gomez J; Elie M; Reisdorph N
Respir Res; 2017 Apr; 18(1):57. PubMed ID: 28403875
[TBL] [Abstract][Full Text] [Related]
18. A pseudo-targeted metabolomics study based on serum bile acids profiling for the differential diagnosis of benign and malignant breast lesions.
Luo C; Zhang X; He Y; Chen H; Liu M; Wang H; Tang L; Tu G; Ding M
Steroids; 2021 Nov; 175():108914. PubMed ID: 34481814
[TBL] [Abstract][Full Text] [Related]
19. Targeted serum metabolite profiling and sequential metabolite ratio analysis for colorectal cancer progression monitoring.
Zhu J; Djukovic D; Deng L; Gu H; Himmati F; Abu Zaid M; Chiorean EG; Raftery D
Anal Bioanal Chem; 2015 Oct; 407(26):7857-63. PubMed ID: 26342311
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
